Last updated: October 2, 2023
Sponsor: Royal Marsden NHS Foundation Trust
Overall Status: Active - Recruiting
Phase
N/A
Condition
Head And Neck Cancer
Human Papilloma Virus (Hpv)
Nasopharyngeal Cancer
Treatment
No intervention.
Clinical Study ID
NCT05909020
CCR5683
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Patients:
- Adults ≥ 18 years referred via suspected HNC pathway without previous history of HNC
- Participants willing and able to give informed consent for participation in the study. Clinicians:
- Staff at participating sites involved in the diagnostic pathway for people withsuspected HNC.
Exclusion
Exclusion Criteria:
- Individuals who do not meet the inclusion criteria.
Study Design
Total Participants: 165
Treatment Group(s): 1
Primary Treatment: No intervention.
Phase:
Study Start date:
March 17, 2023
Estimated Completion Date:
November 30, 2023
Study Description
Connect with a study center
Leeds Teaching Hospitals NHS Trust
Leeds,
United KingdomSite Not Available
Liverpool University Hospitals NHS Foundation Trust
Liverpool,
United KingdomActive - Recruiting
Luton & Dunstable University Hospital
Luton,
United KingdomActive - Recruiting
Oxford NHS Foundation Trust
Oxford,
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.